Medicenna Therapeutics Corp (MDNAF) Live Share Price, Invest From India

Medicenna Therapeutics Corp Stock Performance

as on October 24, 2026 at 6:03 am IST

Day's Low
Day's High
$0.29
Day's Price Range
$0.33
$0.31
5.45%
Downside
7.60%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$0.31
100.00%
Downside
-100.00%
Upside

Medicenna Therapeutics Corp share price movements today

Previous Close: $0.28
Open: $0.33
Volume: 1.1M
Market Cap: $27.7M
Day's Low - High: $0.29 - $0.33

Medicenna Therapeutics Corp Historical Returns

1 Month Return: -0.26 %
3 Month Return: + 20.1 %
1 Year Return: -62.6 %
3 Year Return: 0 %
5 Year Return: 0 %

Medicenna Therapeutics Corp Stock Fundamentals & Key Indicators

Check Medicenna Therapeutics Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$27.7M

EPS (TTM)

-0.2218

Dividend Yield

0.00%

PE Ratio (TTM)

-1.86

Industry PE ratio

-2.60

PEG Ratio

0.06

Return On Equity TTM

-360.29%

Medicenna Therapeutics Corp stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Medicenna Therapeutics Corp with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Medicenna Therapeutics Corp	NA	$27.7M	NA	-1.86	0.00%	0.00%

Stock Returns calculator for Medicenna Therapeutics Corp Stock including INR - Dollar returns

The Medicenna Therapeutics Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Medicenna Therapeutics Corp investment value today

Current value as on today

₹43,647

Returns

-₹56,353

(-56.35%)

Returns from Medicenna Therapeutics Corp Stock

-₹59,645 (-59.64%)

Dollar Impact

₹3,292 (+3.29%)

Medicenna Therapeutics Corp Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	-	-	0	0	0	0	0
Operating Income	-4	0	-5	-5	-5	-5	-5	-5	-7	-5
EBITDA	-4	-4	-5	-5	-5	-5	-4	-5	-7	-5
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-13	-2	-4	-5	0	-4	-4	-4	-5	-5
Income Tax Expense	-	-1	0	-	-1	-	-	-	-1	-
Net Income	-13	-2	-4	-5	1	-4	-4	-4	-4	-5
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	100.00%	0.00%	0.00%	0.00%	0.00%

Medicenna Therapeutics Corp Annual Profit & Loss

All numbers in Millions USD

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Total Revenue	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	-	0	0	0	0	0	0
Operating Income	-7	-4	-8	-17	-22	-21	-19	-21	-23
EBITDA	-7	-4	-8	-17	-22	-16	-18	-12	-23
Interest Expense	-	-	-	-	0	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0
Income Before Tax	-7	-4	-8	-17	-22	-10	-25	-13	-19
Income Tax Expense	0	0	0	0	0	-11	-	-1	-1
Net Income	-7	-4	-8	-17	-22	1	-25	-11	-18
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Medicenna Therapeutics Corp Quarterly Cash Flow

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-13	-2	-4	-5	1	-4	-4	-4	-4	-5
Operating Cash Flow	-4	-3	-5	-3	-4	-3	-4	-4	-4	-4
Investing Cash Flow	-	-	0	-	-	-	-	0	-	-
Financing Cash Flow	-	-	0	1	0	0	0	0	0	3
Change in Cash	-4	-3	-5	0	-5	-4	-4	-5	-4	0

Medicenna Therapeutics Corp Annual Cash Flow

All numbers in Millions USD

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Net Income	-7	-4	-8	-17	-22	-10	-25	-11	-18
Operating Cash Flow	-10	-8	-8	-15	-23	-12	-16	-16	-17
Investing Cash Flow	0	0	-15	5	10	-13	-	0	0
Financing Cash Flow	0	6	44	18	3	24	-	23	0
Change in Cash	-10	-1	20	7	-9	13	-16	7	-18

About Medicenna Therapeutics Corp

Medicenna Therapeutics Corp. is an immunotherapy firm focused on creating and commercializing Superkines and "empowered Superkines" to combat cancer and various other illnesses. Their primary candidate, MDNA55, an interleukin-4 (IL-4) empowered cytokine, has successfully finished Phase IIb trials for recurrent glioblastoma and is also being investigated for other brain and non-brain tumor types in earlier developmental stages. The company's pipeline also includes MDNA11, an improved IL-2 variant designed to stimulate immune responses against cancer; MDNA209, an IL-2 antagonist aimed at autoimmune conditions like multiple sclerosis and graft-versus-host disease; MDNA413, a dual IL-4/IL-13 antagonist for use in cancer immunotherapy; and MDNA132, an IL-13 Superkine targeting solid tumors. Furthermore, Medicenna utilizes its BiSKITs platform to engineer bespoke Superkines by joining them with proteins, antibodies, cytokines, or other Superkines. The company's main office is located in Toronto, Canada.

Organisation	Medicenna Therapeutics Corp
Headquarters	2 Bloor Street West, Toronto, ON, M4W 3E2, CA
Industry	Biotechnology
CEO	Fahar Merchant

Key Management of Medicenna Therapeutics Corp

Name	Title
Dr. Fahar Merchant Ph.D.	Founder, Chairman, President & CEO
Ms. Rosemina Merchant B.Sc., M.E.Sc	Founder & Chief Development Officer
Mr. David Hyman CA, CBV	Chief Financial Officer
Dr. Nageatte Ibrahim M.D.	Chief Medical Officer
Dr. Samuel R. Denmeade M.D.	Scientific Advisor

FAQs

What is Medicenna Therapeutics Corp share price today?

Medicenna Therapeutics Corp share price today is $0.31 as on October 24, 2026 at 12:33 am IST. Medicenna Therapeutics Corp share today touched a day high of $0.33 and a low of $0.29.

What is the 52 week high and 52 week low for Medicenna Therapeutics Corp share?

Medicenna Therapeutics Corp share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. Medicenna Therapeutics Corp stock price today i.e. October 24, 2026 at 12:33 am IST is trending at $0.31,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is Medicenna Therapeutics Corp's market capitalisation today?

Medicenna Therapeutics Corp market capitalisation is $0.00T as on October 24, 2026 at 12:33 am IST.

How to invest in Medicenna Therapeutics Corp Stock (MDNAF) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Medicenna Therapeutics Corp on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Medicenna Therapeutics Corp Stock (MDNAF) from India?

Indian investors can start investing in Medicenna Therapeutics Corp (MDNAF) shares with as little as ₹94.94000244140625 or $1 (as of October 24, 2026 at 1:12 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Medicenna Therapeutics Corp stock (as per the Rupee-Dollar exchange rate as on October 24, 2026 at 1:12 am IST). Based on Medicenna Therapeutics Corp share’s latest price of $0.31 as on October 24, 2026 at 12:33 am IST, you will get 32.6052 shares of Medicenna Therapeutics Corp. Learn more about fractional shares .